Home > Category > Signaling Pathways > JAK/STAT Signaling > JAK > Ritlecitinib Tosylate

Ritlecitinib Tosylate

Catalog No：CL2693A CAS No.：2192215-81-7 MDLNo： Formula：C22H27N5O4S MW：457.55

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Ritlecitinib Tosylate
CAS	2192215-81-7
Formula	C22H27N5O4S
MW	457.55
Appearance	White to off-white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Ritlecitinib, also known as PF-06651600, is a potent and selective JAK3 inhibitor. PF-06651600 is a potent and low clearance compound with demonstrated in vivo efficacy. The favorable efficacy and safety profile of this JAK3-specific inhibitor PF-06651600 led to its evaluation in several human clinical studies. JAK3 was among the first of the JAKs targeted for therapeutic intervention due to the strong validation provided by human SCID patients displaying JAK3 deficiencies.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2693A

Ritlecitinib Tosylate

2192215-81-7 98+%